Literature DB >> 16969832

Clinical variability in type I familial amyloid polyneuropathy (Val30Met): comparison between late- and early-onset cases in Portugal.

Isabel Conceição1, Mamede De Carvalho.   

Abstract

We compared early- with late-onset cases in 86 patients with familial amyloidotic polyneuropathy type I (FAP). Among these patients, 43 presented before age 50 (early-onset) and 43 after this age (late-onset). Sex and geographical distribution were similar, although a family history of the disorder was more frequent in early-onset cases. In late-onset disease, autonomic dysfunction was less frequent, but organ involvement and severe neuropathic pain were more frequent. Neurophysiological measurements were similar. FAP is a cause of neuropathy in elderly patients, in particular in those presenting with neuropathic pain.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 16969832     DOI: 10.1002/mus.20644

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  35 in total

Review 1.  Transthyretin-related amyloidoses and the heart: a clinical overview.

Authors:  Claudio Rapezzi; Candida Cristina Quarta; Letizia Riva; Simone Longhi; Ilaria Gallelli; Massimiliano Lorenzini; Paolo Ciliberti; Elena Biagini; Fabrizio Salvi; Angelo Branzi
Journal:  Nat Rev Cardiol       Date:  2010-05-18       Impact factor: 32.419

2.  Electrophysiological features of late-onset transthyretin Met30 familial amyloid polyneuropathy unrelated to endemic foci.

Authors:  Haruki Koike; Yuichi Kawagashira; Masahiro Iijima; Masahiko Yamamoto; Naoki Hattori; Fumiaki Tanaka; Masaaki Hirayama; Yukio Ando; Shu-ichi Ikeda; Gen Sobue
Journal:  J Neurol       Date:  2008-09-24       Impact factor: 4.849

3.  Genetic and clinical characteristics of hereditary transthyretin amyloidosis in endemic and non-endemic areas: experience from a single-referral center in Japan.

Authors:  Taro Yamashita; Mitsuharu Ueda; Yohei Misumi; Teruaki Masuda; Toshiya Nomura; Masayoshi Tasaki; Kotaro Takamatsu; Keiko Sasada; Konen Obayashi; Hirotaka Matsui; Yukio Ando
Journal:  J Neurol       Date:  2017-11-24       Impact factor: 4.849

4.  Age-dependent cognitive dysfunction in untreated hereditary transthyretin amyloidosis.

Authors:  Ana Martins da Silva; Sara Cavaco; Joana Fernandes; Raquel Samões; Cristina Alves; Márcio Cardoso; Jeffery W Kelly; Cecília Monteiro; Teresa Coelho
Journal:  J Neurol       Date:  2017-12-05       Impact factor: 4.849

5.  TTR familial amyloid polyneuropathy: does a mitochondrial polymorphism entirely explain the parent-of-origin difference in penetrance?

Authors:  Bernard Bonaïti; Malin Olsson; Urban Hellman; Ole Suhr; Catherine Bonaïti-Pellié; Violaine Planté-Bordeneuve
Journal:  Eur J Hum Genet       Date:  2010-03-17       Impact factor: 4.246

6.  Rapid progression of familial amyloidotic polyneuropathy: a multinational natural history study.

Authors:  David Adams; Teresa Coelho; Laura Obici; Giampaolo Merlini; Zoia Mincheva; Narupat Suanprasert; Brian R Bettencourt; Jared A Gollob; Pritesh J Gandhi; William J Litchy; Peter J Dyck
Journal:  Neurology       Date:  2015-07-24       Impact factor: 9.910

7.  Quantitative sensation and autonomic test abnormalities in transthyretin amyloidosis polyneuropathy.

Authors:  Dong Hwee Kim; Steven R Zeldenrust; Phillip A Low; Peter J Dyck
Journal:  Muscle Nerve       Date:  2009-09       Impact factor: 3.217

8.  Familial Transthyretin Amyloidosis with Variant Asp38Ala Presenting with Orthostatic Hypotension and Chronic Diarrhea.

Authors:  Hyun Jun Cho; Jae Yong Yoon; Myung Hwan Bae; Jang Hoon Lee; Dong Heon Yang; Hun Sik Park; Yongkeun Cho; Shung Chull Chae; Jae Eun Jun
Journal:  J Cardiovasc Ultrasound       Date:  2012-12-31

9.  Diagnostic hallmarks and pitfalls in late-onset progressive transthyretin-related amyloid-neuropathy.

Authors:  Maike F Dohrn; Christoph Röcken; Jan L De Bleecker; Jean-Jacques Martin; Matthias Vorgerd; Peter Y Van den Bergh; Andreas Ferbert; Katrin Hinderhofer; J Michael Schröder; Joachim Weis; Jörg B Schulz; Kristl G Claeys
Journal:  J Neurol       Date:  2013-10-08       Impact factor: 4.849

10.  Late-onset familial amyloid polyneuropathy (FAP) Val30Met without family history.

Authors:  Thomas Rudolph; Martin Wilhelm Kurz; Elisabeth Farbu
Journal:  Clin Med Res       Date:  2008-07-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.